News

About Us

Access to Essential Cancer Medicines Symposium at the 2022 World Cancer Congress

Experimental KRAS vaccine generates immune response against pancreatic cancer in people at high risk

Turning the tables on chemotherapy resistance: LIG1 loss exposes a therapeutic vulnerability in triple-negative breast cancer

Early inflammation signal drives oral cancer development, highlights path for immunoprevention

Researchers identify immune cell that builds cancer-fighting hubs inside tumours

Tiny molecules, big possibilities: Researchers explore a new way to slow lung cancer

FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer

Cutting-edge drug shows promise for patients with NRAS-driven melanoma

Researchers developing next-generation cancer therapies by switching off cancer’s DNA repair machinery

Immune cells use previously unknown pathway to eliminate AML

Virtual tumour predict response to liver cancer immunotherapy